Educational Materials

Pivotal Trials that Led to Approval of the Drug as Osteoporosis Therapy

Antiresorptive Therapies

• Residronate (1 - 2 - 3)
• Zoledronate (1)
• Strontium (1 - 2)
• Alendronate (1 - 2)
• Raloxifene (1)
• Calcitonin (1)
• Ibandronate (1)
• Denosumab (1)

Anabolic Therapy

• Parathyroid Hormone (1 - 2 - 3)

Position Statements

• 2010 Official IOF-ISCD Positions on FRAX
   

• ISCD Pediatric and Adult Position statements

ASBMR Webcast Slides Set

Catch the excitement from the ASBMR 2011 Annual Meeting! You can now view select webcasts that showcase cutting-edge scientific presentations from the bone and mineral field.

Third Annual OSTEOS Meeting Slides

December 2, 2011

• MEET THE PROFESSOR SESSION
  • Osteoporosis therapies: When to treat? How to monitor? How long? (Serge Ferrari, Michael McClung)
     
• Use of teriparatide in clinical practice for the treatment of severe osteoporosis: An update (David Kendler)
   
• Updates in osteoporosis treatment (Roger Karam)
   
• Bone health & the vitamin D in light of NCD control
  • Key Findings from the IOF Audit for the Middle East & Africa (Ghada El-Hajj Fuleihan)
  • Lebanon key findings and recommendations for health policy (Rafic Baddoura)
  • The WHO perspective (Ayoub Al-Jawaldeh)
     
• VITAMIN D AND BONE HEALTH SESSION
  • Vitamin D measurement: Laboratory issues (Etienne Cavalier)
  • Vitamin D assays in Lebanon: An overview (Rose Daher)
  • Vitamin D in the Middle East: Current epidemiological evidence (Ghada El-Hajj Fuleihan)
  • Vitamin D current understanding of the vitamin D paradigm and future research perspective (Michael Holick)
     
• MEET THE PROFESSOR SESSION
  • Vitamin D in practice (Roger Bouillon, Etienne Cavalier Bess Dawson-Hughes, Michael Holick)
     
• Vitamin K2 & its role in bone metabolism the missing link (Leon Schurgers)

• MEET THE PROFESSOR SESSION
  • FRAX applications, limitations & new technologies (David Kendler, Ghada El-Hajj Fuleihan)
     
• BONE HEALTH ON THE HORIZON SESSION
  • FRAX guidelines & impact on care
    • The International perspective (Bess Dawson-Hughes)
    • The EMR perspective (Rafic Baddoura)
  • Long term efficacy & safety of osteoporosis therapies (Micheal McClung)
  • New therapies on the horizon from the bench to the bedside (Serge Ferrari)
     
• DENSITOMETRY SESSION
  • The essentials for the clinician (David Kendler)
  • Hands-on case discussion (Ghada El Hajj-Fuleihan)
     
• Bone microarchitecture and bone strength (Rizzoli)
   
• VITAMIN D SESSION
  • Vitamin D: Do we need a lifetime epidemiology approach? (Bess Dawson-Hughes)
  • Developing guidelines for vitamin D intake: Current dilemmas and the move forward (Roger Bouillon)
     
• Optimizing osteoporosis treatment... New Era in osteoporosis management (Serge Ferrari)